Reporter construct of mouse Aicda locus
Clone info. | Reporter construct of mouse Aicda locus with firefly luciferase. Cloned position, not applicable. |
---|---|
Comment | Nat. Immunol. (2010) 2, 148-154, no figure. |
Vector backbone | pGL3 (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Mouse Aicda genomic DNA |
Depositor|Developer | Honjo, Tasuku | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested. (Nat. Immunol., 11, 148-154 (2010)). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Nat. Immunol., 11, 148-154 (2010))。 利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 学術機関の学術研究に限る。 営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。 利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07881 | pGL3-AID R3 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pGL3-AID R3 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07881). |
Reference section:
Tran, T.H., Nakata, M., Suzuki, K., Begum, N.A., Shinkura, R., Fagarasan, S., Honjo, T., Nagaoka, H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07881_A4Gi.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07881_A4Gia.seq ![]() |
---|
>07881_07881_A4Gi_pGL4-4174F_E06_15.ab1 1 ATGGGGGTCA GACATTTCTC TATCGATAGG TACCGAGCTC TTACGCGTGC TAGCCCGGGT 61 CGAGTTTAGA GGAACAGCCT CGAAGGAAGT TGGACATTAA GCATGAGCAG AACTGGCCCC 121 CCCCCCCCAA TCATTTAATC CGTGTGGCTT TGCCCACCAC AGCCCCGCCC ATCTTTACTG 181 GACCCAACCC AGGAGGCAGA TGTTGGATAC CTGGTGGTAG TGATGCTGTC GTGGGGGAGG 241 AGCCCACAAG AGCAAGCTCA GATTTGAATG CCAGGGGCCA GTGCTCTGTC ACACAACAGC 301 ACTGAAGCAG CCTTGCTTGA AGCAAGCTTC CTTTGGCCTA AGACTTTGAG GGAGTCAAGA 361 AAGTCACGCT GGAGACCGAT CCATGGAAGA CGCCAAAAAC ATAAAGAAAG GCCCGGCGCC 421 ATTCTATCCG CTGGAAGATG GAACCGCTGG AGAGCAACTG CATAAGGCTA TGAAGAGATA 481 CGCCCTGGTT CCTGGAACAA TTGCTTTTAC AGATGCACAT ATCGAGGTGG ACATCACTTA 541 CGCTGAGTAC TTCGAAATGT CCGTTCGGTT GGCAGAAGCT ATGAAACGAT ATGGGCTGAA 601 TACAAATCAC AGAATCGTCG TATGCAGTGA AAACTCTCTT CAATTCTTTA TGCCGGTGTT 661 GGGCGCGTTA TTTATCGGAG TTGCAGTTGC GCCCGCGAAC GACATTTATA ATGAACGTGA 721 ATTGCTCAAC AGTATGGGCA TTTCGCAGCC TACCGTGGTG TTCGTTTCCA AAAAGGGGTT 781 GCAAAAAATT TTGAACGTGC AAAAAAAGCT CCCAATCATC CAAAAAATTA TTATCATGGA 841 TTCTAAAACG GATTACCAGG GATTTCAGTC GATGTACACG TTCGTCACAT CTCATCTACC 901 TCCCGGTTTT AATGAATACG ATTTTGTGCC AGAGTCCTTC GATAGGGACA AGACAATTGC 961 ACTGATCATG AACTCCTCTG GGATCTACTG GTCTGCCTAA AGGTGTCGCT CTGCTCATAG 1021 ACTGCCTGCG TGAGATCTCG CATGCAGAGA TCCTATTTTT TGGCATCCAA TCAATTTCGG 1081 GATACTGCGA TTTAATGTGT TCCATCATCA CGATTTGAAA TGTTTACCTA C // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Tran, T.H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806. [link to RRC of NBRP] |
---|
Featured content